Android app on Google Play

Myriad Genetics, Inc. (MYGN) Tops Q1 EPS by 2c; Raises FY

May 1, 2012 4:15 PM EDT Send to a Friend
Myriad Genetics, Inc. (NASDAQ: MYGN) reported Q1 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $129.8 million versus the consensus estimate of $119.2 million.

Myriad Genetics, Inc. raises FY, sees FY2012 revenue of $492-$496 million, versus the consensus of $474 million.

For earnings history and earnings-related data on Myriad Genetics, Inc. (MYGN) click here.

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment